Overview

Poststroke Depression in Hemorrhagic Stroke

Status:
Recruiting

Trial end date:
2024-11-30

Target enrollment:

Participant gender:

Summary

A double-blinded placebo-controlled randomized trial to evaluate the effect of preventative treatment of depression in survivors of aneurysmal subarachnoid hemorrhage (aSAH), a type of stroke.

Phase:

Early Phase 1

Details

Lead Sponsor:

University of Washington

Treatments:

Fluoxetine